Standards; Pharmaceutical/API Drug Impurities/Metabolites;
Droxinostat is a histone deacetylase selective inhibitor and is used in cancer therapy and cancer research. Droxinostat is a selective inhibitor of HDAC3, HDAC6, and HDAC8.
Wood, T.E., et al.: Mol. Cancer. Ther., 9, 246 (2010); Cenik, B., et al.: J. Biol. Chem., 286, 16101 (2011);